Faeth Therapeutics, Inc. ($FTH)
Filing Information
| Accession Number | 0001780030-26-000005 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 26, 2026 |
| Document | View SEC Filing |
Transactions
8
Total Shares
15,641
Total Value
$401,268.52
P&L
-10.9% ($43,558.85)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Common Stock | โ | Jun 24, 2026 | Purchase | 2,891 | $25.22 | $72,911.02 | 20,304 | Indirect | See footnote | View Details | |
Chief Financial Officer | Common Stock | โ | Jun 24, 2026 | Purchase | 3,000 | $25.98 | $77,940.00 | 23,304 | Indirect | See footnote | View Details | |
Chief Financial Officer | Common Stock | โ | Jun 24, 2026 | Purchase | 3,400 | $26.98 | $91,732.00 | 26,704 | Indirect | See footnote | View Details | |
Chief Financial Officer | Common Stock | โ | Jun 24, 2026 | Purchase | 100 | $27.77 | $2,777.00 | 26,804 | Indirect | See footnote | View Details | |
Chief Financial Officer | Common Stock | โ | Jun 26, 2026 | Purchase | 580 | $23.61 | $13,693.80 | 27,384 | Indirect | See footnote | View Details | |
Chief Financial Officer | Common Stock | โ | Jun 26, 2026 | Purchase | 4,212 | $24.90 | $104,878.80 | 31,596 | Indirect | See footnote | View Details | |
Chief Financial Officer | Common Stock | โ | Jun 26, 2026 | Purchase | 1,358 | $25.55 | $34,696.90 | 32,954 | Indirect | See footnote | View Details | |
Chief Financial Officer | Common Stock | โ | Jun 26, 2026 | Purchase | 100 | $26.39 | $2,639.00 | 33,054 | Indirect | See footnote | View Details |